Lamina-associated polypeptide (LAP)2α and nucleoplasmic lamins in adult stem cell regulation and disease

Seminars in Cell and Developmental Biology

Volumn 29, Issue , 2014, Pages 116-124

  Gesson, Kevin ^a   Vidak, Sandra ^a   Foisner, Roland ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Adult stem cells; Laminopathies; Lamins; Nuclear envelopathies; Nuclear envelope; Progeria; Self renewal

Indexed keywords

LAMIN; LAMIN A; LAMIN C; LAMINA ASSOCIATED POLYPEPTIDE 2ALPHA; NUCLEOPLASMIC LAMIN; POLYPEPTIDE; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG; CHROMATIN; DNA BINDING PROTEIN; LAMINA-ASSOCIATED POLYPEPTIDE 2; LMNA PROTEIN, MOUSE; MEMBRANE PROTEIN; NUCLEOPLASMIN;

ADULT STEM CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMATIN; GENE CONTROL; GENE EXPRESSION; HOMEOSTASIS; HUMAN; HUMAN CELL; LAMINOPATHY; MUSCULAR DYSTROPHY; NUCLEAR LAMINA; PREMATURE AGING; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; CELL NUCLEUS MEMBRANE; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE;

ADULT STEM CELLS; AGING, PREMATURE; ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMATIN; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; LAMIN TYPE A; MEMBRANE PROTEINS; MICE; MUSCULAR DYSTROPHIES; NUCLEAR ENVELOPE; NUCLEOPLASMINS; RETINOBLASTOMA PROTEIN;

EID: 84901473315     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2013.12.009     Document Type: Review

References (135)

1. Burke B., Stewart C.L. The nuclear lamins: flexibility in function. Nat Rev Mol Cell Biol 2013, 14:13-24.
2. Dahl K.N., Ribeiro A.J., Lammerding J. Nuclear shape, mechanics, and mechanotransduction. Circ Res 2008, 102:1307-1318.
3. Wilson K.L., Berk J.M. The nuclear envelope at a glance. J Cell Sci 2010, 123:1973-1978.
4. Andres V., Gonzalez J.M. Role of A-type lamins in signaling, transcription, and chromatin organization. J Cell Biol 2009, 187:945-957.
5. Dauer W.T., Worman H.J. The nuclear envelope as a signaling node in development and disease. Dev Cell 2009, 17:626-638.
6. Meister P., Mango S.E., Gasser S.M. Locking the genome: nuclear organization and cell fate. Curr Opin Genet Dev 2011, 21:167-174.
7. Peric-Hupkes D., van Steensel B. Role of the nuclear lamina in genome organization and gene expression. Cold Spring Harb Symp Quant Biol 2010, 75:517-524.
8. Simon D.N., Wilson K.L. The nucleoskeleton as a genome-associated dynamic 'network of networks'. Nat Rev Mol Cell Biol 2011, 12:695-708.
9. Young S.G., Jung H.J., Coffinier C., Fong L.G. Understanding the roles of nuclear A- and B-type lamins in brain development. J Biol Chem 2012, 287:16103-16110.
10. Zuela N., Bar D.Z., Gruenbaum Y. Lamins in development, tissue maintenance and stress. EMBO Rep 2012, 13:1070-1078.
11. Dechat T., Pfleghaar K., Sengupta K., Shimi T., Shumaker D.K., Solimando L., et al. Nuclear lamins: major factors in the structural organization and function of the nucleus and chromatin. Genes Dev 2008, 22:832-853.
12. Dittmer T.A., Misteli T. The lamin protein family. Genome Biol 2011, 12:222.
13. Ho C.Y., Lammerding J. Lamins at a glance. J Cell Sci 2012, 125:2087-2093.
14. Korfali N., Wilkie G.S., Swanson S.K., Srsen V., de Las Heras J., Batrakou D.G., et al. The nuclear envelope proteome differs notably between tissues. Nucleus 2012, 3:552-564.
15. Wilson K.L., Foisner R. Lamin-binding proteins. Cold Spring Harb Perspect Biol 2010, 2:a000554.
16. Butin-Israeli V., Adam S.A., Goldman A.E., Goldman R.D. Nuclear lamin functions and disease. Trends Genet 2012, 28:464-471.
17. Dechat T., Adam S.A., Taimen P., Shimi T., Goldman R.D. Nuclear lamins. Cold Spring Harb Perspect Biol 2010, 2:a000547.
18. Davies B.S., Coffinier C., Yang S.H., Barnes R.H., Jung H.J., Young S.G., et al. Investigating the purpose of prelamin A processing. Nucleus 2011, 2:4-9.
19. Rusinol A.E., Sinensky M.S. Farnesylated lamins, progeroid syndromes and farnesyl transferase inhibitors. J Cell Sci 2006, 119:3265-3272.
20. Sinensky M., Fantle K., Trujillo M., McLain T., Kupfer A., Dalton M. The processing pathway of prelamin A. J Cell Sci 1994, 107(Pt 1):61-67.
21. Dechat T., Gesson K., Foisner R. Lamina-independent lamins in the nuclear interior serve important functions. Cold Spring Harb Symp Quant Biol 2010, 75:533-543.
22. Dechat T., Korbei B., Vaughan O.A., Vlcek S., Hutchison C.J., Foisner R. Lamina-associated polypeptide 2alpha binds intranuclear A-type lamins. J Cell Sci 2000, 113(Pt 19):3473-3484.
23. Moir R.D., Yoon M., Khuon S., Goldman R.D. Nuclear lamins A and B1: different pathways of assembly during nuclear envelope formation in living cells. J Cell Biol 2000, 151:1155-1168.
24. Naetar N., Korbei B., Kozlov S., Kerenyi M.A., Dorner D., Kral R., et al. Loss of nucleoplasmic LAP2alpha-lamin A complexes causes erythroid and epidermal progenitor hyperproliferation. Nat Cell Biol 2008, 10:1341-1348.
25. Berger R., Theodor L., Shoham J., Gokkel E., Brok-Simoni F., Avraham K.B., et al. The characterization and localization of the mouse thymopoietin/lamina-associated polypeptide 2 gene and its alternatively spliced products. Genome Res 1996, 6:361-370.
26. Dechat T., Gotzmann J., Stockinger A., Harris C.A., Talle M.A., Siekierka J.J., et al. Detergent-salt resistance of LAP2alpha in interphase nuclei and phosphorylation-dependent association with chromosomes early in nuclear assembly implies functions in nuclear structure dynamics. EMBO J 1998, 17:4887-4902.
27. Furukawa K., Pante N., Aebi U., Gerace L. Cloning of a cDNA for lamina-associated polypeptide 2 (LAP2) and identification of regions that specify targeting to the nuclear envelope. EMBO J 1995, 14:1626-1636.
28. Harris C.A., Andryuk P.J., Cline S., Chan H.K., Natarajan A., Siekierka J.J., et al. Three distinct human thymopoietins are derived from alternatively spliced mRNAs. Proc Natl Acad Sci USA 1994, 91:6283-6287.
29. Dechat T., Vlcek S., Foisner R. Review: lamina-associated polypeptide 2 isoforms and related proteins in cell cycle-dependent nuclear structure dynamics. J Struct Biol 2000, 129:335-345.
30. Brachner A., Foisner R. Evolvement of LEM proteins as chromatin tethers at the nuclear periphery. Biochem Soc Trans 2011, 39:1735-1741.
31. Cai M., Huang Y., Ghirlando R., Wilson K.L., Craigie R., Clore G.M. Solution structure of the constant region of nuclear envelope protein LAP2 reveals two LEM-domain structures: one binds BAF and the other binds DNA. EMBO J 2001, 20:4399-4407.
32. Dechat T., Gajewski A., Korbei B., Gerlich D., Daigle N., Haraguchi T., et al. LAP2alpha and BAF transiently localize to telomeres and specific regions on chromatin during nuclear assembly. J Cell Sci 2004, 117:6117-6128.
33. Foisner R., Gerace L. Integral membrane proteins of the nuclear envelope interact with lamins and chromosomes, and binding is modulated by mitotic phosphorylation. Cell 1993, 73:1267-1279.
34. Gajewski A., Csaszar E., Foisner R. A phosphorylation cluster in the chromatin-binding region regulates chromosome association of LAP2alpha. J Biol Chem 2004, 279:35813-35821.
35. Vlcek S., Just H., Dechat T., Foisner R. Functional diversity of LAP2alpha and LAP2beta in postmitotic chromosome association is caused by an alpha-specific nuclear targeting domain. EMBO J 1999, 18:6370-6384.
36. Dorner D., Vlcek S., Foeger N., Gajewski A., Makolm C., Gotzmann J., et al. Lamina-associated polypeptide 2alpha regulates cell cycle progression and differentiation via the retinoblastoma-E2F pathway. J Cell Biol 2006, 173:83-93.
37. Markiewicz E., Dechat T., Foisner R., Quinlan R.A., Hutchison C.J. Lamin A/C binding protein LAP2alpha is required for nuclear anchorage of retinoblastoma protein. Mol Biol Cell 2002, 13:4401-4413.
38. Roux K.J., Kim D.I., Raida M., Burke B. A promiscuous biotin ligase fusion protein identifies proximal and interacting proteins in mammalian cells. J Cell Biol 2012, 196:801-810.
39. Taylor M.R., Slavov D., Gajewski A., Vlcek S., Ku L., Fain P.R., et al. Thymopoietin (lamina-associated polypeptide 2) gene mutation associated with dilated cardiomyopathy. Hum Mutat 2005, 26:566-574.
40. Naetar N., Foisner R. Lamin complexes in the nuclear interior control progenitor cell proliferation and tissue homeostasis. Cell Cycle 2009, 8:1488-1493.
41. Markiewicz E., Ledran M., Hutchison C.J. Remodelling of the nuclear lamina and nucleoskeleton is required for skeletal muscle differentiation in vitro. J Cell Sci 2005, 118:409-420.
42. Bonne G., Di Barletta M.R., Varnous S., Becane H.M., Hammouda E.H., Merlini L., et al. Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat Genet 1999, 21:285-288.
43. Capell B.C., Erdos M.R., Madigan J.P., Fiordalisi J.J., Varga R., Conneely K.N., et al. Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci USA 2005, 102:12879-12884.
44. Mendez-Lopez I., Worman H.J. Inner nuclear membrane proteins: impact on human disease. Chromosoma 2012, 121:153-167.
45. Schreiber K.H., Kennedy B.K. When lamins go bad: nuclear structure and disease. Cell 2013, 152:1365-1375.
46. Worman H.J. Nuclear lamins and laminopathies. J Pathol 2012, 226:316-325.
47. Worman H.J., Bonne G. "Laminopathies": a wide spectrum of human diseases. Exp Cell Res 2007, 313:2121-2133.
48. Eriksson M., Brown W.T., Gordon L.B., Glynn M.W., Singer J., Scott L., et al. Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature 2003, 423:293-298.
49. Gotzmann J., Foisner R. A-type lamin complexes and regenerative potential: a step towards understanding laminopathic diseases?. Histochem Cell Biol 2006, 125:33-41.
50. Mattout A., Dechat T., Adam S.A., Goldman R.D., Gruenbaum Y. Nuclear lamins, diseases and aging. Curr Opin Cell Biol 2006, 18:335-341.
51. Zwerger M., Jaalouk D.E., Lombardi M.L., Isermann P., Mauermann M., Dialynas G., et al. Myopathic lamin mutations impair nuclear stability in cells and tissue and disrupt nucleo-cytoskeletal coupling. Hum Mol Genet 2013, 22:2335-2349.
52. Favreau C., Dubosclard E., Ostlund C., Vigouroux C., Capeau J., Wehnert M., et al. Expression of lamin A mutated in the carboxyl-terminal tail generates an aberrant nuclear phenotype similar to that observed in cells from patients with Dunnigan-type partial lipodystrophy and Emery-Dreifuss muscular dystrophy. Exp Cell Res 2003, 282:14-23.
53. Goldman R.D., Shumaker D.K., Erdos M.R., Eriksson M., Goldman A.E., Gordon L.B., et al. Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci USA 2004, 101:8963-8968.
54. Lammerding J., Fong L.G., Ji J.Y., Reue K., Stewart C.L., Young S.G., et al. Lamins A and C but not lamin B1 regulate nuclear mechanics. J Biol Chem 2006, 281:25768-25780.
55. Arimura T., Helbling-Leclerc A., Massart C., Varnous S., Niel F., Lacene E., et al. Mouse model carrying H222P-Lmna mutation develops muscular dystrophy and dilated cardiomyopathy similar to human striated muscle laminopathies. Hum Mol Genet 2005, 14:155-169.
56. Fidzianska A., Hausmanowa-Petrusewicz I. Architectural abnormalities in muscle nuclei. Ultrastructural differences between X-linked and autosomal dominant forms of EDMD. J Neurol Sci 2003, 210:47-51.
57. Swift J., Ivanovska I.L., Buxboim A., Harada T., Dingal P.C., Pinter J., et al. Nuclear lamin-A scales with tissue stiffness and enhances matrix-directed differentiation. Science 2013, 341:1240104.
58. De Vos W.H., Houben F., Kamps M., Malhas A., Verheyen F., Cox J., et al. Repetitive disruptions of the nuclear envelope invoke temporary loss of cellular compartmentalization in laminopathies. Hum Mol Genet 2011, 20:4175-4186.
59. Ho C.Y., Jaalouk D.E., Vartiainen M.K., Lammerding J. Lamin A/C and emerin regulate MKL1-SRF activity by modulating actin dynamics. Nature 2013, 497:507-511.
60. Lammerding J., Schulze P.C., Takahashi T., Kozlov S., Sullivan T., Kamm R.D., et al. Lamin A/C deficiency causes defective nuclear mechanics and mechanotransduction. J Clin Invest 2004, 113:370-378.
61. Verstraeten V.L., Ji J.Y., Cummings K.S., Lee R.T., Lammerding J. Increased mechanosensitivity and nuclear stiffness in Hutchinson-Gilford progeria cells: effects of farnesyltransferase inhibitors. Aging Cell 2008, 7:383-393.
62. Broers J.L., Peeters E.A., Kuijpers H.J., Endert J., Bouten C.V., Oomens C.W., et al. Decreased mechanical stiffness in LMNA-/- cells is caused by defective nucleo-cytoskeletal integrity: implications for the development of laminopathies. Hum Mol Genet 2004, 13:2567-2580.
63. Dechat T., Adam S.A., Goldman R.D. Nuclear lamins and chromatin: when structure meets function. Adv Enzyme Regul 2009, 49:157-166.
64. Nikolova V., Leimena C., McMahon A.C., Tan J.C., Chandar S., Jogia D., et al. Defects in nuclear structure and function promote dilated cardiomyopathy in lamin A/C-deficient mice. J Clin Invest 2004, 113:357-369.
65. Shumaker D.K., Dechat T., Kohlmaier A., Adam S.A., Bozovsky M.R., Erdos M.R., et al. Mutant nuclear lamin A leads to progressive alterations of epigenetic control in premature aging. Proc Natl Acad Sci USA 2006, 103:8703-8708.
66. Muchir A., Pavlidis P., Decostre V., Herron A.J., Arimura T., Bonne G., et al. Activation of MAPK pathways links LMNA mutations to cardiomyopathy in Emery-Dreifuss muscular dystrophy. J Clin Invest 2007, 117:1282-1293.
67. Espada J., Varela I., Flores I., Ugalde A.P., Cadinanos J., Pendas A.M., et al. Nuclear envelope defects cause stem cell dysfunction in premature-aging mice. J Cell Biol 2008, 181:27-35.
68. Hernandez L., Roux K.J., Wong E.S.M., Mounkes L.C., Mutalif R., Navasankari R., et al. Functional coupling between the extracellular matrix and nuclear lamina by Wnt signaling in progeria. Dev Cell 2010, 19:413-425.
69. Marji J., O'Donoghue S.I., McClintock D., Satagopam V.P., Schneider R., Ratner D., et al. Defective lamin A-Rb signaling in Hutchinson-Gilford progeria syndrome and reversal by farnesyltransferase inhibition. PLoS ONE 2010, 5:e11132.
70. Osorio F.G., Lopez-Otin C., Freije J.M. NF-kB in premature aging. Aging (Albany, NY) 2012, 4:726-727.
71. Cupesi M., Yoshioka J., Gannon J., Kudinova A., Stewart C.L., Lammerding J. Attenuated hypertrophic response to pressure overload in a lamin A/C haploinsufficiency mouse. J Mol Cell Cardiol 2010, 48:1290-1297.
72. Johnson B.R., Nitta R.T., Frock R.L., Mounkes L., Barbie D.A., Stewart C.L., et al. A-type lamins regulate retinoblastoma protein function by promoting subnuclear localization and preventing proteasomal degradation. Proc Natl Acad Sci USA 2004, 101:9677-9682.
73. Mariappan I., Parnaik V.K. Sequestration of pRb by cyclin D3 causes intranuclear reorganization of lamin A/C during muscle cell differentiation. Mol Biol Cell 2005, 16:1948-1960.
74. Bridger J.M., Kill I.R. Aging of Hutchinson-Gilford progeria syndrome fibroblasts is characterised by hyperproliferation and increased apoptosis. Exp Gerontol 2004, 39:717-724.
75. Mounkes L.C., Kozlov S., Hernandez L., Sullivan T., Stewart C.L. A progeroid syndrome in mice is caused by defects in A-type lamins. Nature 2003, 423:298-301.
76. Scaffidi P., Misteli T. Lamin A-dependent misregulation of adult stem cells associated with accelerated ageing. Nat Cell Biol 2008, 10:452-459.
77. Bakay M., Wang Z.Y., Melcon G., Schiltz L., Xuan J.H., Zhao P., et al. Nuclear envelope dystrophies show a transcriptional fingerprint suggesting disruption of Rb-MyoD pathways in muscle regeneration. Brain 2006, 129:996-1013.
78. Frock R.L., Kudlow B.A., Evans A.M., Jameson S.A., Hauschka S.D., Kennedy B.K., et al. Lamin A/C and emerin are critical for skeletal muscle satellite cell differentiation. Genes Dev 2006, 20:486-500.
79. Boguslavsky R.L., Stewart C.L., Worman H.J. Nuclear lamin A inhibits adipocyte differentiation: implications for Dunnigan-type familial partial lipodystrophy. Hum Mol Genet 2006, 15:653-663.
80. Akter R., Rivas D., Geneau G., Drissi H., Duque G. Effect of lamin A/C knockdown on osteoblast differentiation and function. J Bone Miner Res 2009, 24:283-293.
81. Rauner M., Sipos W., Goettsch C., Wutzl A., Foisner R., Pietschmann P., et al. Inhibition of lamin A/C attenuates osteoblast differentiation and enhances RANKL-dependent osteoclastogenesis. J Bone Miner Res 2009, 24:78-86.
82. Heessen S., Fornerod M. The inner nuclear envelope as a transcription factor resting place. EMBO Rep 2007, 8:914-919.
83. Kind J., van Steensel B. Genome-nuclear lamina interactions and gene regulation. Curr Opin Cell Biol 2010, 22:320-325.
84. Mancini M.A., Shan B., Nickerson J.A., Penman S., Lee W.H. The retinoblastoma gene product is a cell cycle-dependent, nuclear matrix-associated protein. Proc Natl Acad Sci USA 1994, 91:418-422.
85. Ozaki T., Saijo M., Murakami K., Enomoto H., Taya Y., Sakiyama S. Complex formation between lamin A and the retinoblastoma gene product: identification of the domain on lamin A required for its interaction. Oncogene 1994, 9:2649-2653.
86. Weinberg R.A. The retinoblastoma protein and cell cycle control. Cell 1995, 81:323-330.
87. Van Berlo J.H., Voncken J.W., Kubben N., Broers J.L., Duisters R., van Leeuwen R.E., et al. A-type lamins are essential for TGF-beta1 induced PP2A to dephosphorylate transcription factors. Hum Mol Genet 2005, 14:2839-2849.
88. Rodriguez J., Calvo F., Gonzalez J.M., Casar B., Andres V., Crespo P. ERK1/2 MAP kinases promote cell cycle entry by rapid, kinase-independent disruption of retinoblastoma-lamin A complexes. J Cell Biol 2010, 191:967-979.
89. Gotic I., Schmidt W.M., Biadasiewicz K., Leschnik M., Spilka R., Braun J., et al. Loss of LAP2 alpha delays satellite cell differentiation and affects postnatal fiber-type determination. Stem Cells 2010, 28:480-488.
90. Gotic I., Foisner R. Multiple novel functions of lamina associated polypeptide 2alpha in striated muscle. Nucleus 2010, 1:397-401.
91. Jahn D., Schramm S., Schnolzer M., Heilmann C.J., de Koster C.G., Schutz W., et al. A truncated lamin A in the Lmna -/- mouse line: implications for the understanding of laminopathies. Nucleus 2012, 3:463-474.
92. Cohen T.V., Gnocchi V.F., Cohen J.E., Phadke A., Liu H., Ellis J.A., et al. Defective skeletal muscle growth in lamin A/C-deficient mice is rescued by loss of Lap2alpha. Hum Mol Genet 2013, 22:2852-2869.
93. Constantinescu D., Gray H.L., Sammak P.J., Schatten G.P., Csoka A.B. Lamin A/C expression is a marker of mouse and human embryonic stem cell differentiation. Stem Cells 2006, 24:177-185.
94. Eckersley-Maslin M.A., Bergmann J.H., Lazar Z., Spector D.L. Lamin A/C is expressed in pluripotent mouse embryonic stem cells. Nucleus 2013, 4:53-60.
95. Zuo B., Yang J., Wang F., Wang L., Yin Y., Dan J., et al. Influences of lamin A levels on induction of pluripotent stem cells. Biol Open 2012, 1:1118-1127.
96. Wagers A.J., Weissman I.L. Plasticity of adult stem cells. Cell 2004, 116:639-648.
97. Pekovic V., Hutchison C.J. Adult stem cell maintenance and tissue regeneration in the ageing context: the role for A-type lamins as intrinsic modulators of ageing in adult stem cells and their niches. J Anat 2008, 213:5-25.
98. Mateos J., De la Fuente A., Lesende-Rodriguez I., Fernandez-Pernas P., Arufe M.C., Blanco F.J. Lamin A deregulation in human mesenchymal stem cells promotes an impairment in their chondrogenic potential and imbalance in their response to oxidative stress. Stem Cell Res 2013, 11:1137-1148.
99. Rosengardten Y., McKenna T., Grochova D., Eriksson M. Stem cell depletion in Hutchinson-Gilford progeria syndrome. Aging Cell 2011, 10:1011-1020.
100. Lavasani M., Lu A., Thompson S.D., Robbins P.D., Huard J., Niedernhofer L.J. Isolation of muscle-derived stem/progenitor cells based on adhesion characteristics to collagen-coated surfaces. Methods Mol Biol 2013, 976:53-65.
101. Meshorer E., Gruenbaum Y. Rejuvenating premature aging. Nat Med 2008, 14:713-715.
102. Halaschek-Wiener J., Brooks-Wilson A. Progeria of stem cells: stem cell exhaustion in Hutchinson-Gilford progeria syndrome. J Gerontol A Biol Sci Med Sci 2007, 62:3-8.
103. Prokocimer M., Davidovich M., Nissim-Rafinia M., Wiesel-Motiuk N., Bar D.Z., Barkan R., et al. Nuclear lamins: key regulators of nuclear structure and activities. J Cell Mol Med 2009, 13:1059-1085.
104. Gilchrist S., Gilbert N., Perry P., Ostlund C., Worman H.J., Bickmore W.A. Altered protein dynamics of disease-associated lamin A mutants. BMC Cell Biol 2004, 5:46.
105. Markiewicz E., Venables R., Mauricio Alvarez R., Quinlan R., Dorobek M., Hausmanowa-Petrucewicz I., et al. Increased solubility of lamins and redistribution of lamin C in X-linked Emery-Dreifuss muscular dystrophy fibroblasts. J Struct Biol 2002, 140:241-253.
106. Muchir A., Medioni J., Laluc M., Massart C., Arimura T., van der Kooi A.J., et al. Nuclear envelope alterations in fibroblasts from patients with muscular dystrophy, cardiomyopathy, and partial lipodystrophy carrying lamin A/C gene mutations. Muscle Nerve 2004, 30:444-450.
107. Wiesel N., Mattout A., Melcer S., Melamed-Book N., Herrmann H., Medalia O., et al. Laminopathic mutations interfere with the assembly, localization, and dynamics of nuclear lamins. Proc Natl Acad Sci USA 2008, 105:180-185.
108. Dechat T., Shimi T., Adam S.A., Rusinol A.E., Andres D.A., Spielmann H.P., et al. Alterations in mitosis and cell cycle progression caused by a mutant lamin A known to accelerate human aging. Proc Natl Acad Sci USA 2007, 104:4955-4960.
109. Favreau C., Higuet D., Courvalin J.C., Buendia B. Expression of a mutant lamin A that causes Emery-Dreifuss muscular dystrophy inhibits in vitro differentiation of C2C12 myoblasts. Mol Cell Biol 2004, 24:1481-1492.
110. Kandert S., Wehnert M., Muller C.R., Buendia B., Dabauvalle M.C. Impaired nuclear functions lead to increased senescence and inefficient differentiation in human myoblasts with a dominant p.R545C mutation in the LMNA gene. Eur J Cell Biol 2009, 88:593-608.
111. Varela I., Cadinanos J., Pendas A.M., Gutierrez-Fernandez A., Folgueras A.R., Sanchez L.M., et al. Accelerated ageing in mice deficient in Zmpste24 protease is linked to p53 signalling activation. Nature 2005, 437:564-568.
112. Meaburn K.J., Cabuy E., Bonne G., Levy N., Morris G.E., Novelli G., et al. Primary laminopathy fibroblasts display altered genome organization and apoptosis. Aging Cell 2007, 6:139-153.
113. De Falco G., Comes F., Simone C. pRb: master of differentiation. Coupling irreversible cell cycle withdrawal with induction of muscle-specific transcription. Oncogene 2006, 25:5244-5249.
114. Cremer T., Cremer M. Chromosome territories. Cold Spring Harb Perspect Biol 2010, 2:a003889.
115. Misteli T. Beyond the sequence: cellular organization of genome function. Cell 2007, 128:787-800.
116. Clowney E.J., LeGros M.A., Mosley C.P., Clowney F.G., Markenskoff-Papadimitriou E.C., Myllys M., et al. Nuclear aggregation of olfactory receptor genes governs their monogenic expression. Cell 2012, 151:724-737.
117. Solovei I., Wang A.S., Thanisch K., Schmidt C.S., Krebs S., Zwerger M., et al. LBR and lamin A/C sequentially tether peripheral heterochromatin and inversely regulate differentiation. Cell 2013, 152:584-598.
118. Greil F., Moorman C., van Steensel B. DamID: mapping of in vivo protein-genome interactions using tethered DNA adenine methyltransferase. Methods Enzymol 2006, 410:342-359.
119. Vogel M.J., Peric-Hupkes D., van Steensel B. Detection of in vivo protein-DNA interactions using DamID in mammalian cells. Nat Protoc 2007, 2:1467-1478.
120. Guelen L., Pagie L., Brasset E., Meuleman W., Faza M.B., Talhout W., et al. Domain organization of human chromosomes revealed by mapping of nuclear lamina interactions. Nature 2008, 453:948-951.
121. Finlan L.E., Sproul D., Thomson I., Boyle S., Kerr E., Perry P., et al. Recruitment to the nuclear periphery can alter expression of genes in human cells. PLoS Genet 2008, 4:e1000039.
122. Kumaran R.I., Spector D.L. A genetic locus targeted to the nuclear periphery in living cells maintains its transcriptional competence. J Cell Biol 2008, 180:51-65.
123. Reddy K.L., Zullo J.M., Bertolino E., Singh H. Transcriptional repression mediated by repositioning of genes to the nuclear lamina. Nature 2008, 452:243-247.
124. Meister P., Towbin B.D., Pike B.L., Ponti A., Gasser S.M. The spatial dynamics of tissue-specific promoters during C. elegans development. Genes Dev 2010, 24:766-782.
125. Peric-Hupkes D., Meuleman W., Pagie L., Bruggeman S.W., Solovei I., Brugman W., et al. Molecular maps of the reorganization of genome-nuclear lamina interactions during differentiation. Mol Cell 2010, 38:603-613.
126. Kind J., Pagie L., Ortabozkoyun H., Boyle S., de Vries S.S., Janssen H., et al. Single-cell dynamics of genome-nuclear lamina interactions. Cell 2013, 153:178-192.
127. Towbin B.D., Gonzalez-Aguilera C., Sack R., Gaidatzis D., Kalck V., Meister P., et al. Step-wise methylation of histone H3K9 positions heterochromatin at the nuclear periphery. Cell 2012, 150:934-947.
128. Meuleman W., Peric-Hupkes D., Kind J., Beaudry J.B., Pagie L., Kellis M., et al. Constitutive nuclear lamina-genome interactions are highly conserved and associated with A/T-rich sequence. Genome Res 2013, 23:270-280.
129. Zullo J.M., Demarco I.A., Pique-Regi R., Gaffney D.J., Epstein C.B., Spooner C.J., et al. DNA sequence-dependent compartmentalization and silencing of chromatin at the nuclear lamina. Cell 2012, 149:1474-1487.
130. Shimi T., Pfleghaar K., Kojima S., Pack C.G., Solovei I., Goldman A.E., et al. The A- and B-type nuclear lamin networks: microdomains involved in chromatin organization and transcription. Genes Dev 2008, 22:3409-3421.
131. Kubben N., Adriaens M., Meuleman W., Voncken J.W., van Steensel B., Misteli T. Mapping of lamin A- and progerin-interacting genome regions. Chromosoma 2012, 121:447-464.
132. Bruston F., Delbarre E., Ostlund C., Worman H.J., Buendia B., Duband-Goulet I. Loss of a DNA binding site within the tail of prelamin A contributes to altered heterochromatin anchorage by progerin. FEBS Lett 2010, 584:2999-3004.
133. McCord R.P., Nazario-Toole A., Zhang H., Chines P.S., Zhan Y., Erdos M.R., et al. Correlated alterations in genome organization, histone methylation, and DNA-lamin A/C interactions in Hutchinson-Gilford progeria syndrome. Genome Res 2013, 23:260-269.
134. Lund E., Oldenburg A.R., Delbarre E., Freberg C.T., Duband-Goulet I., Eskeland R., et al. Lamin A/C-promoter interactions specify chromatin state-dependent transcription outcomes. Genome Res 2013.
135. Zhang S., Schones D.E., Malicet C., Rochman M., Zhou M., Foisner R., et al. High mobility group protein N5 (HMGN5) and lamina-associated polypeptide 2alpha (LAP2alpha) interact and reciprocally affect their genome-wide chromatin organization. J Biol Chem 2013, 288:18104-18109.